Claranova (CLA) H1 2025 TU earnings summary

Executive summary

• H1 2024-2025 revenue reached €294m, stable year-over-year despite a challenging holiday calendar impacting key markets in the US and UK.

• Teams managed logistical and commercial hurdles, maintaining sales and improving operating margins.

• Deconsolidation of the myDevices division, now considered non-core and in the process of being sold.

• Legal proceedings with former executive Pierre Cesarini resulted in a favorable ruling for Claranova in Luxembourg.

Financial highlights

• H1 2024-2025 revenue: €294m, down 1% year-over-year at actual exchange rates.

• Q2 2024-2025 revenue: €206m, nearly flat compared to €207m in the prior year.

• Double-digit EBITDA growth expected for H1 2024-2025, driven by cost management and strategic initiatives.

Outlook and guidance

• Reaffirmed FY 2026-2027 targets: 5%-8% CAGR, €575m-€625m annual revenue, EBITDA margin of 13%-15%, and net financial debt/EBITDA ratio below 1x.

• Avanquest division expects new technologies and applications to drive H2 2024-2025 growth.